Gefässchirurgie

, Volume 12, Issue 6, pp 401–412

Prämature Atherosklerose

Risikofaktor männliches Geschlecht
Leitthema
  • 52 Downloads

Zusammenfassung

Die koronare Herzerkrankung (KHK) ist bei Männern und Frauen die Haupttodesursache. Männer entwickeln aufgrund einer prämaturen Atherosklerose die KHK jedoch 10 Jahre früher. Dies verkürzt die Lebenserwartung des Mannes um etwa 6 Jahre. Jüngere und mittelalte Männer haben bei gleichem Blutdruck- oder Cholesterinwert ein doppelt so hohes kardiovaskuläres Risiko wie Frauen bzw. das gleiche Risiko wie 10 Jahre ältere Frauen. Das männliche Geschlecht ist neben dem Alter ein nicht beeinflussbarer wesentlicher Risikofaktor. Diese Geschlechterdifferenz bei atherosklerotischen Folgeerkrankungen, die sich erst im Alter >75 Jahre ausgleicht, kann über die unterschiedlichen Sexualhormone nicht erklärt werden. Die bisherige Datenlage erlaubt derzeit keine definitive Erklärung der prämaturen Atherosklerose beim Mann. Parallel zur KHK haben Männer auch häufiger und in früherem Alter eine periphere arterielle Verschlusskrankheit (pAVK) oder auch abdominelle und thorakale Aortenaneurysmen.

Schlüsselwörter

Prämature Atherosklerose Geschlechterdifferenz Myokardinfarkt pAVK Aortenaneurysma 

Premature atherosclerosis

Male sex as a risk factor

Abstract

Coronary heart disease (CAD) is the leading cause of death in men and women. However, men develop heart disease about 10 years earlier, which reduces their average life expectancy by about 6 years. The cause is the high incidence of premature atherosclerosis in men. In fairly young and middle-aged men with the same blood pressure or cholesterol levels as women cardiovascular risk is double that in women the same age, or the same as in women 10 years older but with the same risk factor profile otherwise. This means that like age, male sex is a cardiovascular risk factor that noone can do anything about. The sex difference does not even out until after the age of 75 years and cannot be explained on the basis of the different sex hormones. The data currently available do not allow any definitive explanation for the premature atherosclerosis seen in men. In parallel with CAD, men also suffer more frequently and earlier in life than women from peripheral arterial disease and aortic aneurysms.

Keywords

Premature atherosclerosis Gender gap Myocardial infarction Peripheral arterial disease Aortic aneurysm 

Literatur

  1. 1.
    Akkersdijk GJM, Prinssen M, Blankensteijn JD (2004) The impact of endovascular treatment on in-hospital mortality following non-ruptured AAA repair over a decade: A population based study of 16446 patients. Eur J Vasc Endovasc Surg 28: 41–46PubMedCrossRefGoogle Scholar
  2. 2.
    Assmann G, Cullen P, Jossa F et al. (1999) Coronary heart disease: reducing the risk. The scientific background to primary and secondary prevention of coronary heart disease. A worldwide view. International Task Force for the Prevention of Coronary Heart Disease. Arterioscler Thromb Vasc Biol 19: 1819–1824PubMedGoogle Scholar
  3. 3.
    Assmann G, Cullen P, Schulte H (2002) Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Münster (PROCAM) Study. Circulation 105: 310–315PubMedCrossRefGoogle Scholar
  4. 4.
    Barrett-Connor E, Khaw KT (1988) Endogenous sex hormones and cardiovascular disease in men. A prospective population based study. Circulation 78: 539–545PubMedGoogle Scholar
  5. 5.
    Barrett-Connor E (1997) Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys lecture. Circulation 95: 252–264PubMedGoogle Scholar
  6. 6.
    Benjamin EJ, Wolf PA, D’Agostino RB et al. (1998) Impact of atrial fibrillation on the risk of death. The Framingham Heart study. Circulation 98: 946–952PubMedGoogle Scholar
  7. 7.
    Burt VL, Whelton P, Rocella EJ et al. (1995) 1995 prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension 25: 305–313PubMedGoogle Scholar
  8. 8.
    CAPRIE Steering Committee (1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348: 1329–1339CrossRefGoogle Scholar
  9. 9.
    Collins P, Stevenson JC, Mosca L (2002) Spotlight on gender. Cardiovasc Res 53: 535–537PubMedCrossRefGoogle Scholar
  10. 10.
    Conroy RM, Pyörälä K, Fitzgerald AP et al. (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24: 987–1003PubMedCrossRefGoogle Scholar
  11. 11.
    Coronary Drug Project Research Group (1973) The Coronary Drug Project. Findings leading to discontinuation of the 2,5 mg day estrogen group. JAMA 226: 652–657CrossRefGoogle Scholar
  12. 12.
    Dagenais GR, Maurice S, Robitaille NM et al. (1991) Intermittent claudication in Quebec men from 1974–1986: the Quebec Cardiovascular Study. Clin Invest Med 14: 93–100PubMedGoogle Scholar
  13. 13.
    D’Amico AV, Denham JW, Crook J et al. (2007) Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions. J Clin Oncol 25: 2420–2425CrossRefGoogle Scholar
  14. 14.
    Dormandy JA, Rutherford RB (2000) Management of peripheral arterial disease (PAD). TASC Working Group. Transatlantic Inter-Society Consensus (TASC). J Vasc Surg 31: S1–S296PubMedCrossRefGoogle Scholar
  15. 15.
    Dueck AD, Kucey DS, Johnston KW et al. (2004) Survival after ruptured aortic aneurysm: effect of patient, surgeon, and hospital factors. J Vasc Surg 39: 1253–1260PubMedCrossRefGoogle Scholar
  16. 16.
    Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285: 2486–2497CrossRefGoogle Scholar
  17. 17.
    Feldman HA, Johannes CB, Araujo AB et al. (2001) Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging Study. Am J Epidemiol 153: 79–89PubMedCrossRefGoogle Scholar
  18. 18.
    Freedman S, Srinivasan DS, Webber LS (1987) Black-white differences in serum lipoproteins during sexual maturation: The Bogalusa Heart Study. J Chron Dis 40: 309–318PubMedCrossRefGoogle Scholar
  19. 19.
    Gan SG, Beaver SK, Houck PM et al. (2000) Treatment of acute myocardial infarction and the 30-day mortality among women and men. N Engl J Med 343: 8–15PubMedCrossRefGoogle Scholar
  20. 20.
    Gheeraert PJ, De Buyzere ML, Taeymans YM et al. (2006) Risk factors for primary ventricular fibrillation during acute myocardial infarction: a systematic review and meta-analysis. Eur Heart J 27: 2499–2510PubMedCrossRefGoogle Scholar
  21. 21.
    Goldstein LB, Adams R, Alberts MJ et al. (2006) AHA/ASA Guidelines. Primary prevention of ischemic stroke. Circulation 113: e873–e923PubMedCrossRefGoogle Scholar
  22. 22.
    Gustafsson F, Torp-Pedersen C, Burchardt H et al. (2004) Female sex is associated with a better long-term survival in patients hospitalized with congestive heart failure. Eur Heart J 25: 129–135PubMedCrossRefGoogle Scholar
  23. 23.
    Hamilton JB, Mestler GE (1969) Mortality and survival: comparison of eunuchs with intact men and women in a mentally retarded population. J Gerontol 24: 395–411PubMedGoogle Scholar
  24. 24.
    Harman SM, Metter EJ, Tobin JD et al. (2001) Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab 86: 724–731PubMedCrossRefGoogle Scholar
  25. 25.
    Hatakeyama N, Nishizawa M, Nakagawa A et al. (2002) Testosterone inhibits tumor necrosis factor-alpha-induced vascular cell adhesion molecule-1 expression in human aortic endothelial cells. FEBS Lett 530: 129–132PubMedCrossRefGoogle Scholar
  26. 26.
    Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360: 7–22CrossRefGoogle Scholar
  27. 27.
    Heer T, Gitt AK, Juenger C et al. (2006) Gender differences in acute non-ST-segment elevation myocardial infarction. Am J Cardiol 98: 160–166PubMedCrossRefGoogle Scholar
  28. 28.
    Hiatt WR (2001) Medical treatment of peripheral arterial disease and claudication. N Engl J Med 344: 1608–1621PubMedCrossRefGoogle Scholar
  29. 29.
    Hochman JS, Tamis JE, Thompson TD et al. (1999) Sex, clinical presentation, and outcome in patients with acute coronary syndromes. N Engl J Med 341: 226–232PubMedCrossRefGoogle Scholar
  30. 30.
    Hultgren R, Granath F, Swedenborg J et al. (2007) Different disease profiles for women and men with abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 33: 556–560PubMedCrossRefGoogle Scholar
  31. 31.
    Jenkins JS (1998) The voice of the castrato. Lancet 352: 1877–1880CrossRefGoogle Scholar
  32. 32.
    Jeppesen LL, Jorgensen HS, Nakayama H et al. (1996) Decreased serum testosterone in men with acute ischemic stroke. Arterioscler Thromb Vasc Biol 16: 749–754PubMedGoogle Scholar
  33. 33.
    Kalin MF, Zumoff B (1990) Sex hormones and coronary disease: a review of the clinical studies. Steroids 55: 330–352PubMedCrossRefGoogle Scholar
  34. 34.
    Kannel WB, McGee DL (1985) Update on some epidemiological features of intermittent claudication. J Am Geriatr Soc 33: 13–18PubMedGoogle Scholar
  35. 35.
    Kannel WB, Wilson PWF, D’Agostino RB et al. (1998) Sudden coronary death in women. Am Heart J 136: 205–212PubMedCrossRefGoogle Scholar
  36. 36.
    Kannel WB, Wolf PA, Benjamin EJ et al. (1998) Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation. Am J Cardiol 82: 2N–9NPubMedCrossRefGoogle Scholar
  37. 37.
    Kaplan NM (1998): Clinical hypertension. 7th edn. Williams & Wilkins, BaltimoreGoogle Scholar
  38. 38.
    Keil U, Fitzgerald AP, Wellmann J et al. (2005) Risikoabschätzung tödlicher Herz-Kreislauf-Erkrankungen. Dtsch Arztebl 102: A1808–A1812Google Scholar
  39. 39.
    Kerr CR, Humphries K (2005) Gender-related differences in atrial fibrillation. J Am Coll Cardiol 46: 1307–1308PubMedCrossRefGoogle Scholar
  40. 40.
    Leng CC, Lee AJ, Fowkes FGR et al. (1996) Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 25: 1172–1181PubMedCrossRefGoogle Scholar
  41. 41.
    Lerner DJ, Kannel WB (1986) Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham Population. Am J Cardiol 111: 383–390Google Scholar
  42. 42.
    Levy D, Kannel WB (1988) Cardiovascular risks: new insights from Framingham. Am Heart J 116: 266–272PubMedCrossRefGoogle Scholar
  43. 43.
    Levy D, Kannel WB (2000) Searching for answers to ethnic disparities in cardiovascular risk. Lancet 356: 266–267PubMedCrossRefGoogle Scholar
  44. 44.
    Levy D, Kenchaiah S, Larson MG et al. (2002) Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347: 1397–1402PubMedCrossRefGoogle Scholar
  45. 45.
    Liu PY, Death AK, Handelsman DJ (2003) Androgens and cardiovascular death. Endocr Rev 24: 313–340PubMedCrossRefGoogle Scholar
  46. 46.
    Mäkinen J, Järvisalo MJ, Pöllänen P et al. (2005) Increased carotid atherosclerosis in andropausal middle-aged men. J Am Coll Cardiol 45: 1603–1608PubMedCrossRefGoogle Scholar
  47. 47.
    McCullough PA, Philbin EF, Spertus JA et al. (2002) Confirmation of a heart failure epidemic: findings from the resource utilization among congestive heart failure (REACH) study. J Am Coll Cardiol 39: 60–69PubMedCrossRefGoogle Scholar
  48. 48.
    McRae S, Tran H, Schulman S et al. (2006) Effect of patient’s sex on risk of recurrent venous thromboembolism: a meta-analysis. Lancet 368: 371–378PubMedCrossRefGoogle Scholar
  49. 49.
    Morrison JA, Laskarzewski PM, Rauh JL (1979) Lipids, lipoproteins, and sexual maturation during adolescence: The Princeton Maturation Study. Metabolism 28: 641–649PubMedCrossRefGoogle Scholar
  50. 50.
    Morrison JA, Sprecher DL, Biro FM et al. (2002) Serum testosterone associates with lower high density lipoprotein cholesterol in black and white males, 10–15 years of age, through lowered apolipoprotein AI and AII concentrations. Metabolism 51: 432–437PubMedCrossRefGoogle Scholar
  51. 51.
    Mosca L, Manson JE, Sutherland SE et al. (1997) Cardiovascular disease in women. A statement for healthcare professionals from the American Heart Association. Circulation 96: 2468–2482PubMedGoogle Scholar
  52. 52.
    Muller M, Beld AW van den, Bots ML et al. (2004) Endogenous sex hormones and progression of carotid atherosclerosis in elderly men. Circulation 109: 2074–2079PubMedCrossRefGoogle Scholar
  53. 53.
    Natarajan S, Liao Y, Cao G et al. (2003) Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease. Arch Intern Med 163: 1735–1740PubMedCrossRefGoogle Scholar
  54. 54.
    Nienhaber CA, Fattori R, Mehta R et al. (2004) Gender-related differences in acute aortic dissection. Circulation 109: 3014–3021CrossRefGoogle Scholar
  55. 55.
    Nieschlag E, Nieschlag S, Behre HM (1993) Lifespan and testosterone. Nature 366: 1011–1017CrossRefGoogle Scholar
  56. 56.
    Norman PE, Semmens JB, Lawrence-Brown M et al. (2000) The influence of gender on outcome following peripheral vascular surgery: a review. Cardiovasc Surg 8: 111–115PubMedCrossRefGoogle Scholar
  57. 57.
    Olsson C, Eriksson N, Stähle E et al. (2007) Surgical and long-term mortality in 2634 consecutive patients operated on the proximal thoracic aorta. Eur J Cardiothorac Surg 31: 963–969PubMedCrossRefGoogle Scholar
  58. 58.
    O’Meara E, Clayton T, McEntegart M et al. (2007) Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure. Results from the Candesartan in Heart failure: Assessment of reduction in mortality and morbidity (CHARM) Program. Circulation 115: 3111–3120CrossRefGoogle Scholar
  59. 59.
    Parzeller M (2003) Deutsche Ärztezeitung vom 23.09.2003Google Scholar
  60. 60.
    Priori SG, Aliot E, Blomstrom-Lundqvist C et al. (2001) Task force on sudden cardiac death of the European Society of Cardiology. Eur Heart J 22: 1374–1450PubMedCrossRefGoogle Scholar
  61. 61.
    PROGESS Collaborative Group (2001) Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 358: 1033–1041CrossRefGoogle Scholar
  62. 62.
    Qureshi NA, Rehman A, Slater N et al. (2007) Abdominal aortic aneurysm surgery in a district general hospital: A 15 years experience. Ann Vasc Surg 16: May [Epub ahead of print]Google Scholar
  63. 63.
    Reinecke H, Bogdanski J, Woltering A et al. (2002) Relation of serum levels of sex hormone binding globulin to coronary heart disease in postmenopausal women. Am J Cardiol 90: 364–368PubMedCrossRefGoogle Scholar
  64. 64.
    Rich-Edwards JW, Manson JA, Hennekens CH et al. (1995) The primary prevention of coronary heart disease in women. N Engl J Med 332: 1758–1766PubMedCrossRefGoogle Scholar
  65. 65.
    Rienstra M, Van Veldhuisen DJ, Hagens VE et al. (2005) Gender-related differences in rhythm control treatment in persistent atrial fibrillation. Data of the rate control versus electrical cardioversion (RACE) study. J Am Coll Cardiol 46: 1298–1306PubMedCrossRefGoogle Scholar
  66. 66.
    Roquer J, Campello AR, Gomis M (2003) Sex differences in first-ever acute stroke. Stroke 34: 1581–1585PubMedCrossRefGoogle Scholar
  67. 67.
    Rossouw JE (2000) Women and coronary heart disease. In: Betteridge DJ (ed) Lipids and vascular disease – current issues. Dunitz, LondonGoogle Scholar
  68. 68.
    Sacco RL, Benjamin EJ, Broderick JP et al. (1997) American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors. Stroke 28: 1507–1517PubMedGoogle Scholar
  69. 69.
    Sakalihasan N, Limet R, Defawe OD (2005) Abdominal aortic aneurysm. Lancet 365: 1577–1589PubMedCrossRefGoogle Scholar
  70. 70.
    Shores MM, Matsumoto AM, Sloan KL et al. (2006) Low serum testosterone and mortality in male veterans. Arch Intern Med 166: 1660–1885PubMedCrossRefGoogle Scholar
  71. 71.
    Simon T, Mary-Krause M, Funck-Brentano C et al. (2001) Sex differences in the prognosis of congestive heart failure. Results from the Cardiac Insufficiency Bisoprolol study (CIBIS II). Circulation 103: 375–380PubMedGoogle Scholar
  72. 72.
    Strödter D (2004) Sekundärprävention bei KHK und Postinfarktpatienten – Strategien und Resultate, 2. Aufl. Uni-Med Science, BremenGoogle Scholar
  73. 73.
    Strödter D (2006) MännerGesundheit – Editorial. Klinikarzt 35: 56CrossRefGoogle Scholar
  74. 74.
    Strödter D (2006) Prämature Atherosklerose –was ist die Ursache? Klinikarzt 35: 57–61CrossRefGoogle Scholar
  75. 75.
    Strödter D (2006) Kardiale Erkrankungen und Sekundärprävention beim Mann. Klinikarzt 35: 62–67CrossRefGoogle Scholar
  76. 76.
    Svartberg J, Muhlen D von, Mathiesen E et al. (2006) Low testosterone levels are associated with carotis atherosclerosis in men. J Intern Med 259: 576–582PubMedCrossRefGoogle Scholar
  77. 77.
    The United Kingdom Small Aneurysm Trial Participants (2002) Long-term outcomes of immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med 346: 1445–1452CrossRefGoogle Scholar
  78. 78.
    The Veterans Administration Co-operative Urological Research Group (1967) Treatment and survival of patients with cancer of the prostate. Surg Gynecol Obstet 124: 1011–1017Google Scholar
  79. 79.
    The World Health Report (2002) World Health Organization, GenevaGoogle Scholar
  80. 80.
    Vaccarino V, Parsons L, Every NR et al. (1999) Sex-based differences in early mortality after myocardial infarction. N Engl J Med 341: 217–225PubMedCrossRefGoogle Scholar
  81. 81.
    Visser P, Akkersdijk GJM, Blankensteijn JD (2005) In-hospital operative mortality of ruptured abdominal aortic aneurysm. A population-based analysis of 5593 patients in The Netherlands over a period over a 10-year period. Eur J Vasc Endovasc Surg 30: 359–364PubMedCrossRefGoogle Scholar
  82. 82.
    Van Kesteren PJ, Ascheman H, Megens JA et al. (1997) Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clin Endocrinol (Oxf) 47: 337–342Google Scholar
  83. 83.
    Vasan RS, Larson MG, Leip EP et al. (2002) Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 345: 1291–1297CrossRefGoogle Scholar
  84. 84.
    Weidemann W, Hanke H (2002) Cardiovascular effects of androgens. Cardiovasc Drug Rev 20: 175–198PubMedCrossRefGoogle Scholar
  85. 85.
    Wenger NK (2002) Clinical characteristics of coronary heart disease in women: emphasis on gender differences. Cardiovasc Res 53: 558–567PubMedCrossRefGoogle Scholar
  86. 86.
    White HD, Barbash GI, Modan M et al. (1993) After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. Circulation 88: 2097–2103PubMedGoogle Scholar
  87. 87.
    Widmer LK, Biland S (1985) Incidence and course of occlusive peripheral artery disease in geriatric patients. Int Angiol 4: 289–294PubMedGoogle Scholar
  88. 88.
    Wilson JD, Roehrborn C (1999) Long-term consequence of castration in men: lessons from the Skoptzy and the eunuchs of the Chinese and Ottoman courts. J Clin Endocrinol Metab 84: 4324–4331PubMedCrossRefGoogle Scholar
  89. 89.
    World Health Organization (1999) International Society of Hypertension Guidelines for the management of hypertension. Guidelines Subcommittee. J Hypertens 17: 151–183Google Scholar
  90. 90.
    Wu FCW, Eckardstein A von (2003) Androgens and coronary artery disease. Endocr Rev 24: 183–187PubMedCrossRefGoogle Scholar
  91. 91.
    Yarnell JWG, Beswick AD, Sweetnam PM et al. (1993) Endogenous sex hormones and ischemic heart disease in men. The Caerphilly prospective study. Arterioscler Thromb 13: 517–520PubMedGoogle Scholar
  92. 92.
    Yu HY, Chen YS, Huang SC et al. (2004) Late outcome of patients with aortic dissection. Study of a national database. Eur J Cardiothorac Surg 25: 683–690PubMedCrossRefGoogle Scholar
  93. 93.
    Zitzman M, Nieschlag E (2001) Testosterone levels in healthy men and their relation to behavioural and physical characteristics: facts and constructs. Eur J Endocrinol 144: 183–187CrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag 2007

Authors and Affiliations

  1. 1.1. Med. Klinik und PoliklinikUniversität GießenGießenDeutschland

Personalised recommendations